Iridoids from leaves of Gelsemium elegans

Area of Science:

• Natural Product Chemistry
• Phytochemistry
• Organic Chemistry

Background:

• Gelsemium elegans is a plant species known for its bioactive compounds.
• Iridoids and iridoid glycosides are classes of natural products with diverse pharmacological properties.
• Understanding the chemical constituents of Gelsemium elegans can lead to the discovery of novel therapeutic agents.

Purpose of the Study:

• To isolate and characterize novel iridoids and iridoid glycosides from Gelsemium elegans leaves.
• To elucidate the structures of these isolated compounds using spectroscopic and chemical methods.
• To evaluate the potential of these compounds in promoting neurite outgrowth in PC12 cells.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation through Nuclear Magnetic Resonance (NMR) spectroscopy, Mass Spectrometry (MS), and other spectroscopic analyses.
• Determination of relative and absolute configurations using X-ray crystallography and modified Mosher's method.
• Biological evaluation of selected compounds for PC12 cell neurite outgrowth activity.

Main Results:

• Six new iridoids, designated geleganoids A-F, were isolated.
• Five iridoid glycosides, including two new compounds (geleganosides A and B) and three previously reported ones, were identified.
• The structures of all isolated compounds were fully elucidated.
• The relative configuration of geleganoid A was confirmed by X-ray diffraction.
• The absolute configuration of geleganoid B was determined.
• None of the tested compounds exhibited significant PC12 cell neurite outgrowth activity.

Conclusions:

• The study successfully identified and characterized novel iridoid and iridoid glycoside compounds from Gelsemium elegans.
• The isolated compounds, despite their structural novelty, did not demonstrate efficacy in promoting neurite outgrowth in the PC12 cell model.
• Further research may explore other biological activities of these Gelsemium elegans constituents.